dievini Hopp BioTech holding
dievini Hopp BioTech holding is the evergreen life-sciences family-office holding of SAP co-founder Dietmar Hopp and his family, based in Walldorf, Germany. Formalized in 2005 and led today by managing director Dr. Mathias Hothum (with founders Friedrich von Bohlen und Halbach and Christof Hettich), it invests patient balance-sheet capital directly into biotech, therapeutics and diagnostics companies focused on oncology, neurology, infectiology, cell therapy and pharmaceutical formulations, primarily in Germany and Europe. Notable holdings include CureVac, Immatics, AC Immune, Apogenix, Heidelberg Pharma and Molecular Health, with more than EUR 1.3 billion deployed across its portfolio.
Key facts
Recent exits
Coverage notes
1 fund tracked, 6 portfolio companies (5 active · 1 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund dievini Hopp BioTech holding has raised, with its portfolio companies. Hand-checked from public filings.
dievini Hopp BioTech holding (Evergreen Balance Sheet)Evergreen2005 · 21yr€1.4B5 active · 1 realized
Unrealized
5 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Apogenix | Biotech | Germany | 2005 |
| Heidelberg Pharma | Biotech | Germany | 2009 |
| Immatics | Biotech | Germany | 2006 |
| Molecular Health | SaaS | Germany | 2004 |
| Novaliq | Pharma | Germany | 2007 |
Saved GPs appear in your watchlist, one click from your workspace.
Similar firms
Other private equity firms tracked on GP Intel.